Clinical Trials on Loeys-Dietz Syndrome

Total 34666 results

University of California, San Francisco

Completed

Diet Quality and LTL in NHANES

Diet Habit | Telomere Length, Mean Leukocyte
Laboratorios Sophia S.A de C.V.

Completed

Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV) (087LATAMFIV)

Dry Eye Syndrome

Mexico
Gazi University

Completed

Two Different Dietary Interventions for Girls With Polycystic Ovary Syndrome

Obesity | Polycystic Ovary Syndrome | Diet, Healthy | Androgen; Hypersecretion

Turkey
DTU National Food Institute
University Hospital Bispebjerg and Frederiksberg

Recruiting

Jodkids: a Study of Iodine Intake Among Children Aged 2-10 Years

Diet Habit | Iodine Deficiency | Iodine Toxicity

Denmark
VA Office of Research and Development

Recruiting

Peer-Led Diet and Exercise Intervention

Physical Activity | Diet Quality | Peer Leaders

United States
PepsiCo Global R&D

Completed

A Cross-sectional Online Survey Among Saudi Arabian Population in the Age Group 18-40 Years to Assess Whole Grain (WG) Awareness, Consumption Levels, and Dietary Habits Around Breakfast

Diet, Healthy

Saudi Arabia
Eastern Mediterranean University

Enrolling by invitation

Acute Effects of Herbal Dietary Supplements on Aerobic Performance

Diet, Healthy

Cyprus
DoubleGood AB
starScience GmbH

Completed

Using CGM for Evaluating Effects of Food on Glucose Regulation in Healthy Humans

Glycemic Control | Diet, Food and Nutrition

Sweden
University Ghent

Completed

The Influence of the Microbiome on the Pharmacokinetics of Flavan-3-ols (PhTI)

Diet Modification

Belgium
Cornell University

Completed

The Effect of Dietary Lauric Acid on the Production of the LRH-1 Ligand, Dilauroylphosphatidylcholine (DLauricPC)

Diet Modification

United States
Duke University

Terminated

Measurements From Stool to Support Dietary Change

Feeding Behavior | Diet Habit | Behavior, Health

United States
Appalachian State University
University of North Carolina, Chapel Hill

Completed

Influence of Flavonoids and Caffeine Supplementation on Resting Metabolism

Diet Modification

United States
University of Illinois at Urbana-Champaign

Completed

Effects of Recess Timing and Activity on Children's Eating Behaviors

Physical Activity | Health Behavior | Diet Habit
MRC Human Nutrition Research

Completed

Bioavailability of Green Tea and Coffee Polyphenols (POBAS)

Dietary Supplements | Diet, Food, and Nutrition

United Kingdom
James Lewis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Controlled Feeding Experiment (CaFE)

Effect of Diet on Microbiome Composition

United States
National Taiwan University Hospital
Buddhist Tzu Chi General Hospital; Taipei Medical University Hospital; E-DA Hospital and other collaborators

Unknown

Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet

Colonoscopy | Colon Cleansing | Low-Reside Diet

Taiwan
Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

Japan
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Recruiting

Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care (FISiM-NGS-MDS)

MDS (Myelodysplastic Syndrome)

Italy
Novartis Pharmaceuticals

Active, not recruiting

STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS

Myelodysplastic Syndrome (MDS)

United States
Fujifilm Pharmaceuticals U.S.A., Inc.

Withdrawn

A Study of FF-10501-01 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety of ON 01910.Na in Patients With Myelodysplasia

Myelodysplastic Syndrome (MDS)

United States
Telik

Terminated

Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
Oncology Specialties, Alabama

Terminated

Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome (MDS)

United States
Groupe Francophone des Myelodysplasies
Bristol-Myers Squibb; AbbVie

Recruiting

Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes

Untreated Myelodysplastic Syndrome

France
Case Comprehensive Cancer Center

Recruiting

CPX-351 Therapy for MDS After Hypomethylating Agent Failure

Myelodysplastic Syndrome (MDS)

United States
Novartis Pharmaceuticals

Completed

A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants (STIMULUS-MDS3)

Myelodysplastic Syndrome (MDS)

France, Spain, Belgium, Italy, Greece, Hungary, Germany
Weill Medical College of Cornell University
Novartis Pharmaceuticals

Completed

MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions (T2*MRI)

Myelodysplastic Syndrome (MDS)

United States
Incyte Corporation

Terminated

Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)

MDS (Myelodysplastic Syndrome)

United States
Chinese Society of Hematology
Harbin Institute of Hematology & Oncology

Unknown

Myelodysplastic Syndrome--CDA-2 Hematological Improvement National Affirmation Study (MD-CHINA)

Myelodysplastic Syndrome (MDS)
Asociación Andaluza de Hematología y Hemoterapia

Completed

Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia (ABRAZA)

Myelodysplastic Syndrome (MDS)

Spain
Genzyme, a Sanofi Company

Terminated

Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome (RISE)

Myelodysplastic Syndrome (MDS)

Germany, United Kingdom, France, Netherlands
Heinrich-Heine University, Duesseldorf

Terminated

Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome (VALENA)

Myelodysplastic Syndrome MDS

Germany
Telik

Terminated

Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
Telik

Completed

Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome (MDS)

United States
Seagen Inc.

Completed

A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndrome (MDS)

United States
zhang shoulong
Changhai Hospital; Jinan Military General Hospital

Recruiting

Biomarker and Imaging Package Study in Immune Effector Cell-Associated Neurotoxicity Syndrome

Immune Effector Cell Associated Neurotoxicity Syndrome

China
AbbVie
Genentech, Inc.

Active, not recruiting

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome (Verona)

Myelodysplastic Syndrome (MDS)

United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
Amphivena Therapeutics, Inc.

Completed

A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes

Myelodysplastic Syndrome (MDS)

United States
Celgene

Completed

Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

China
Amgen

Completed

Darbepoetin Alfa MDS Companion Protocol

Myelodysplastic Syndrome (MDS)

Belgium
Novartis Pharmaceuticals

Terminated

LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS) (GEPARD)

Myelodysplastic Syndrome (MDS)

Germany
Telik

Completed

Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome (MDS)

United States
University College Dublin
Queen's University, Belfast; University College Cork; Teagasc

Completed

Dietary Intervention Study on Food Based Dietary Guidelines for Sustainable and Healthy Lifestyles (SuHeGuide)

Dietary Habits | Healthy Diet | Healthy Nutrition | Personalized Nutrition

Ireland, United Kingdom
University of Copenhagen
Movesca ApS; Departmen for rehabilitation M3, Hobro Hospital

Completed

Intervention of Diet Registration Method for Rehabilitation Patients

Digital Clinical Diet Registrations Advantages | Patients in Rehabilitation

Denmark
Fundació Eurecat

Completed

Collaborative and Adaptive Recommender for Personalized DIEt Management (CarpeDiem)

Physical Activity | Sleep | Life Style, Healthy | Diet Habit

Spain
Federico II University

Completed

Mediterranean Diet, Trimethylamine N-oxide (TMAO) and Anti-oxidants in Healthy Adults (TMED)

Cardiovascular Risk Factor | Mediterranean Diet | Trimethylamine N-oxide
Maastricht University Medical Center

Completed

Resistance Exercise in Healthy Men

Single Bout of Resistance Type Exercise | Standardized Diet

Netherlands
Thomas Jefferson University
AbbVie

Recruiting

Evaluating Navitoclax After Failure of Standard Treatments of Azacitidine or Decitabine and Venetoclax in Patients With Aggressive Myelodysplastic Syndrome

Myelodysplastic Syndrome | Recurrent Myelodysplastic Syndrome | Refractory Myelodysplastic Syndrome

United States
University of Wisconsin, Madison

Terminated

Botox for the Treatment of Chronic Exertional Compartment Syndrome

Compartment Syndrome of Leg

United States
Scripps Health
J. Craig Venter Institute

Completed

Biomarker Monitoring in TP53 Mutation Carriers

Li-Fraumeni Syndrome | Hereditary Cancer Syndromes | TP53 Gene Germline Mutation Carrier

United States

Clinical Trials on Loeys-Dietz Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations